baber/WOPTO huggingface dataset:
Patent DK-1412448-T3 (DK)
Inventor: AUDIBERT ANNIE
IPC: C09K8/04
Filed: 2001-06-25
Granted: 2009-02-16
Abstract: The present invention relates to a method and a fluid for drilling or intervening in a well passing through a porous, permeable formation, wherein a water-based well fluid is circulating in said well. In this method, there is added to the fluid not only the conventional ingredients for such a fluid but also a maximum of 10 wt. % of a composition obtained from a grease or oil and an alcohol, with the chain lengths of the acid and alcohol parts being chosen such that the ester thus obtained has sufficient dispersion in water, compatibility with said ingredients, does not form an emulsion with the reservoir oil, and adsorbs sufficiently on the porous formation.
Patent DK-1316981-T3 (DK)
Inventor: BLANK THOMAS
IPC: H05K1/00
Filed: 2002-11-26
Granted: 2008-01-02
Abstract: Assembly has first, outer board and second drilled board sitting on first plate with one electrically conductive ball per drill hole. First outer plate has identical ring disks regularly arranged, with electrical contact tab extending radially outwards to edge of its zone, in same alignment within each row. Second board drillings match ring disk matrix layout with aligned axes, each with electrically conductive inner wall with electrically conductive contact tab extending radially outwards to edge of its zone. Third board, of non-conductive material, covers drillings of second board with hermetic seal. <??>The multiple ball switch, in a layered board structure, has an initial board as the outer board with identical circular ring disks of an electrically conductive material in a matrix layout. Each circular ring disk has at least one electrical contact tab extending radially outwards to the edge of its zone, with the contact tabs in the same alignment within each row. A second board to be laid on the first, has drillings through it matching the ring disk matrix layout with aligned axes, each with an electrically conductive inner wall fitted with an electrically conductive contact tab extending radially outwards to the edge of its zone, all in the same alignment in each row. The conductive surfaces of the first board have no direct contact with conductive surfaces of the second board. A ball of electrically conductive material is inserted into each drilling of dimensions so that, when there is an electrical contact between the ring disk and the conductive inner wall of the drilling, it does not project from the drilling and there is no space for a second ball. A third board, of non-conductive material, covers the drillings of the second board with a hermetic seal. The switch assembly is produced using surface mounted device (SMD) technology.
Patent DK-1233186-T3 (DK)
Inventor: MATSUURA DAI
IPC: F04C18/356
Filed: 2002-02-01
Granted: 2004-10-25
Abstract: A rotary compressor which uses carbonic acid gas as the refrigerant, polyalkylene glycol as a lubricant, or polyalfa olefin or mineral oil as a base oil. The compressor includes a roller and a vane whose radius of curvature (Rv) (cm) at a sliding contact portion with respect to said roller can be represented by the following Expression (1): <DF NUM="Expression (1)">T < Rv < Rr </DF> where T is the thickness (cm) of the vane, and Rr is the radius of curvature (cm) of the outer periphery of the roller which slidingly comes into contact with the vane. <IMAGE>
Patent DK-1379917-T3 (DK)
Inventor: GEHRING THOMAS R
IPC: G03B21/62
Filed: 2002-01-10
Granted: 2008-06-16
Abstract: A flexible screen with a mechanism for releasably attaching the screen to a transparent door or window is disclosed. A method of use is also disclosed.
Patent DK-1467235-T3 (DK)
Inventor: EBERHARDT COLIN
IPC: G02B21/00
Filed: 2004-04-07
Granted: 2007-10-08
Abstract: According to a first embodiment the invention provides, for achieving fast multi-wavelength scanning in an acousto-optical deflector (5) based confocal scanning microscope, dynamically adjusting an optical path of said acousto-optical deflector (5) based confocal microscope by mechanical means in accordance with a selected wavelength of a laser light beam (1), to compensate for astigmatism and collimation changes due to the change in input beam wavelength and modifying detected images of an object by electronic means to maintain alignment of the scan lines of the image at all wavelengths. According to a second embodiment the invention provides, for achieving fast multi-wavelength scanning in an acousto-optical deflector (5) based laser confocal scanning microscope, dynamically adjusting drive parameters of the acousto-optical deflector (5) in accordance with the selected wavelength of the input laser light beams, to maintain alignment of the scan lines of the image at all wavelengths. According to a third embodiment the invention provides, for achieving fast multi-wavelength scanning in an acousto-optical deflector (5) based laser confocal scanning microscope dynamically adjusting drive parameters of the acousto-optical deflector (5) in accordance with the selected wavelength of the input laser light beams, to maintain alignment of the scan lines of the image at all wavelengths, and mechanically pivoting the acousto-optical deflector (5) about its central axis to compensate for the different deflection angles and ranges of the used illumination wavelengths. <IMAGE>
Patent DK-1479484-T3 (DK)
Inventor: RICORDI CHRISTIAN PAUL A
IPC: B25C1/08
Filed: 2004-05-21
Granted: 2010-10-18
Abstract: A port (52) is employed for a fan chamber (50) which defines a volume formed by at least one generally continuous vertical wall (56) connecting a horizontal base wall with an opposing horizontal exit wall (54). Within the volume is a fan rotatable in a plane generally parallel to a plane of at least one of the horizontal walls. The port (52) is formed of an inner side (62) located between a center (60) of the exit wall (54) and an outer edge of said wall (56), an outer side (64) located between the inner side (62) and the outer edge (66) of the exit wall (56), and two opposing secant sides (68, 70) connecting respective ends of the outer side (64) to the inner side (62). A shape of the inner side (62) forms a straight line or a convex line with respect to the center (60) of the exit wall.
Patent DK-1650730-T3 (DK)
Inventor: VERSTRAETE GERRIT
IPC: F21V9/00
Filed: 2004-10-25
Granted: 2010-05-03
Abstract: A display has a spatial light modulator 10 for dynamically controlling a luminance of each pixel according to an input signal, the spatial light modulator having a non uniform spatial characteristic, the display also having an optical filter 20 having a spatial pattern to alter the luminance to compensate at least partially for the non uniform spatial characteristic. An electronic signal processing element applies some pre compensation predominantly of higher spatial frequencies for the non uniform spatial characteristic. Such dynamic and optical compensation can enable tuning for different optimizations or for compensating for variations over time. A backlight has an optical source and an optical filter, the source having a colour output which has a non uniform spatial characteristic, and the optical filter having a spatial pattern to alter the colour to compensate in part at least for the non uniform spatial characteristic.
Patent DK-1587537-T3 (DK)
Inventor: COSTANTINO PAOLO
IPC: A61K39/02
Filed: 2004-01-30
Granted: 2012-07-16
Abstract: An injectable immunogenic composition comprising capsular saccharides from at least two of serogroups A, C, W135 and Y of  Neisseria meningitidis,  wherein said capsular saccharides are conjugated to carrier protein(s) and/or are oligosaccharides, and wherein i) the composition comprises less than 50 µg meningococcal saccharide per dose, and/or ii) the composition further comprises an antigen from one or more of: (a) serogroup B  N.meningitidis;  (b)  Haemophilus influenzae  type B; and/or (c)  Streptococcus pneumoniae.
Patent DK-1720583-T3 (DK)
Inventor: ZENOBI MAURO
IPC: A61M1/02
Filed: 2004-02-09
Granted: 2007-10-29
Abstract: The apparatus for receiving, preserving and supplying bags of blood comprises a cabinet for containing all the components of the apparatus; a refrigerated space for containing the bags; a magazine comprising a plurality of cells, each capable of containing a single bag, the magazine being housed inside the refrigerated space, each of the cells being identified by a cell code; at least one door for allowing access by an operator to the cells; a movement system housed inside the cabinet and capable of moving, preferably rotating, the cells; a cooling system housed inside the cabinet and capable of cooling the refrigerated space; a data processing system housed inside the cabinet, capable of controlling the movement system and the cooling system, and capable of controlling the receiving, preservation and supply of the bags; a keyboard and a screen, both connected to the processing system, and both placed at the walls of the cabinet.
Patent DK-1635838-T3 (DK)
Inventor: KREISEL WOLFGANG
IPC: A61K38/095
Filed: 2004-06-03
Granted: 2007-09-10
Abstract: Phosphodiesterase type 5 inhibitor (I) is used to prevent or treat portal hypertension and associated disorders. Phosphodiesterase type 5 inhibitor (I) is used to prevent or treat portal hypertension; to prevent or treat hemorrhagic complications of portal hypertension, hepatorenal syndrome, hepatopulmonary syndrome, hepatic encephalopathy, spontaneous bacterial peritonitis and ascites; to prevent or treat diseases that can be ameliorated or prevented by lowering portal vein pressure and/or increasing portal vein blood flow; for modulating the metabolism of a substance, where such modulation comprises increasing portal vein blood flow and thus increasing hepatic blood flow. An independent claim is also included for a combination medication for preventing or treating portal hypertension and/or disease states or risks associated with portal hypertension, comprising a phosphodiesterase type 5 inhibitor (II) and another agent active against portal hypertension. ACTIVITY : Hypotensive; Hepatotropic; Nephrotropic; Antiinflammatory; Antibacterial. MECHANISM OF ACTION : Phosphodiesterase type 5 inhibitor.
Patent DK-1647286-T3 (DK)
Inventor: SHIMOJI HIROYUKI
IPC: A61B17/06
Filed: 2004-07-16
Granted: 2010-11-29
Abstract: The present invention relates to a tubular suture reinforcement material suitable for use in automatic suturing devices that are widely used in surgical operations, etc. More specifically, the present invention relates to a tubular suture reinforcement material with which a tubular shape is easily obtained to thereby increase its productivity, and removal of thread is easily achieved. The present invention aims to overcome drawbacks such that sheet-like materials joined by the conventional temporary adhesion easily separate from each other, and the tubular suture reinforcement material manufactured using a running stitch requires a lot of time and skill, and removal of the thread is difficult depending on the kind of sheet-like material, sewing pitch, etc. More specifically, the present invention relates to a tubular suture reinforcement material for an automatic suturing device, wherein both ends of one or two sheet-like materials are sewed using a chain stitch (intralooping stitch) with a single thread to form a tubular shape, and one or two thread ends at one or two sewing ends are suitably extended.
Patent DK-1663225-T3 (DK)
Inventor: JIN BETTY
IPC: A23K20/195
Filed: 2004-08-26
Granted: 2011-11-21
Abstract: Compositions including polymeric dialdehydes and compounds of where R1, R2, R7, R8, R9, and R10 may be the same or different and are selected from H, CH3, OH, OCH3, C2H5, OC2H5OCH2Ph, OCH2PhNO2, F or Cl; R3, R4, R5, R6 may be the same or different and are selected from H, CH3, OCH3, C2H5, OC2H5OCH2Ph, OCH2PhNO2, F or Cl, or R5 and R6 are the same or different and are selected from H, CH3, OCH3, C2H5, OC2H5OCH2Ph, OCH2PhNO2, F or Cl and R3 and R4 together are ═O, or R4 and R6 are the same or different and are selected from H, CH3, OCH3, C2H5, OC2H5OCH2Ph, OCH2PhNO2, F or Cl and R3 and R5 together form a double bond or are ═O, or R3 and R4, are the same or different and are selected from H, CH3, OCH3, C2H5, OC2H5OCH2Ph, OCH2PhNO2, F or Cl and R5 and R6 together are ═O; R11 and R12 together form ═CH2, or R11 and R12 may be the same or different and are independently selected from the group consisting of H, CH3, CH2CH3 and CH2CH2CH3; and X is selected from the group consisting of Cl, Br, SO4, I and R13COO, where R13 is CH3 or poly acids, for the treatment of gastrointestinal functional disorders or related conditions as well as for the promotion of general health and weight gain in animals including humans.
Patent DK-1666033-T3 (DK)
Inventor: STEINER MITCHELL S
IPC: A61P15/10
Filed: 2002-11-27
Granted: 2009-04-06
Abstract: This invention relates to the use of a selective estrogen receptor modulator (SERM) for the preparation of a pharmaceutical composition for treating androgen-deprivation induced loss of bone mineral density (BMD) or androgen-deprivation induced bone fractures in a male subject having prostate cancer.
Patent DK-1722729-T3 (DK)
Inventor: STROEBECH ESBEN
IPC: A61F5/44
Filed: 2005-02-28
Granted: 2009-12-07
Abstract: An ostomy system for receiving bodily waste having a gas impermeable outer bag and a water impermeable inner bag enclosed within the outer bag, as well as a coupling system for attaching the bag to the body of a patient and for securing the outer bag in relation to the inner bag. The coupling system defines an orifice to enable bodily waste to be received by the inner bag and includes a barrier for preventing liquids and solid particles from passing from the inner bag to the outer bag, at least part of the barrier being permeable to flatus gasses. The barrier may be in the form of a foam. The outer bag has an outlet with a flatus filter for releasing flatus gases from the outer bag. An inner bag is provided, which maintains its physical integrity, e.g. its buoyancy, upon immersion in water.
Patent DK-1718734-T3 (DK)
Inventor: BUERSTEDDE JEAN-MARIE
IPC: C12N5/06
Filed: 2005-02-23
Granted: 2008-02-25
Abstract: The invention relates to a modified lymphoid cell having gene conversion fully or partially replaced by hypermutation, wherein said cell has no deleterious mutations in genes encoding paralogues and analogues of the RAD51 protein, and wherein said cell is capable of directed and selective genetic diversification of a target nucleic acid by hypermutation or a combination of hypermutation and gene conversion. The invention also relates to a method for diversifying any transgenic target gene in said cell. Preferably, the target gene is integrated into the immunoglobulin light or heavy chain locus by targeted integration.
Patent DK-1793707-T3 (DK)
Inventor: FRIEDRICHS ARNO
IPC: A47C27/10
Filed: 2005-08-25
Granted: 2009-02-02
Abstract: The bed has a mattress (1) with a set of air chambers (2), each equipped with an air supply. The bed is equipped with a set of controllable valves, each assigned to one of the air chambers. A control unit is connected to a set of sensors and individually controls the valves in accordance with output signals of the sensors. An air source is connected to the valves. The air chambers are sensor controllably filled by the control unit.
Patent DK-1843757-T3 (DK)
Inventor: KNIPPER-BREER MARLIES
IPC: A61K31/00
Filed: 2006-01-19
Granted: 2010-07-26
Abstract: Use of a compound (I) interacting with brain-derived nerve growth factor (BDNF)-signal transduction cascade for the production of a medicament to treat phantom phenomena of acute tinnitus and/or phantom pain in human or animal. Independent claims are also included for: (1) diagnosing phantom phenomena of the acute tinnitus and/or phantom pain in human or animal, comprising supplying a biological sample, determining the level of the expression of BDNF in the biological sample, comparing the level with a reference value from a healthy organism, and correlating a level lying over the healthy organism with a positive diagnosis; and (2) treating phantom phenomena of the acute tinnitus and/or phantom pain in human or animal, comprising supplying a medicament that exhibits a substance interacting with BDNF signal transduction cascade, and applying the medicament locally to the organism, and optionally repeating the method. ACTIVITY : Auditory; Analgesic. MECHANISM OF ACTION : Brain-derived nerve growth factor (BDNF)-signal transduction cascade blocker; BDNF-signal transduction cascade inhibitor; Gamma aminobutyric acid receptor agonist; L-type-Ca ++>-channel antagonist; Cyclic adenosine monophosphate response element binding protein (CREP) antagonist; Glutamate antagonist; Mitogen activated protein-kinase-inhibitor; Calmodulin-dependent kinase-inhibitor; Tyrosine kinase linked receptor (trkB) antagonist. The ability of (I) to inhibit BDNF-signal transduction cascade was tested in cochlea. (I) Significantly removed the expressions of BNDF Exon-IV.
Patent DK-1877329-T3 (DK)
Inventor: COSTANZO MARK
IPC: B65G47/68
Filed: 2006-05-03
Granted: 2009-05-11
Abstract: A conveyor and associated method for diverting closely spaced articles conveyed along the conveyor. The conveyor includes a conveyor belt with belt rollers oriented to rotate on axes oblique to the direction of belt travel. A series of arrays of bearing surface elements are arranged end to end along the length of the conveyor. The bearing surfaces may be static or rotational. Each array defines a roller-control zone in which the array is selectively activated with its bearing surface elements in contract with the belt rollers or deactivated with its bearing surface elements out of contact with the belt rollers. As the belt advances through an activated roller-control zone, the belt rollers rotate to propel a conveyed article toward a side of the belt. The contiguous roller-control zones are sequentially activated and deactivated to direct articles to the side and off the belt or to let them pass straight through. The length of the entire series of roller-control zones determines the lateral extent of the sidewise diversion. The length of each roller-control zone determines the minimum gap between consecutively conveyed articles. The serial cascade of these roller-control zones permits the tight sortation of closely spaced articles for high throughput.
Patent DK-1899394-T3 (DK)
Inventor: INGRISCH STEFAN
IPC: C04B24/28
Filed: 2006-06-30
Granted: 2009-08-03
Abstract: The invention describes amphiphilic polymer compounds which have been prepared by a) reacting a di-, tri- or tetraglycidyl compound (A) with an optionally unsaturated reactive component (B) consisting of C<SUB>8</SUB>-C<SUB>28</SUB>-fatty acid, a C<SUB>8</SUB>-C<SUB>28</SUB>-alcohol or a secondary C<SUB>8</SUB>-C<SUB>28</SUB>-amine, and then b) allowing the reaction product from stage a) to react with an aliphatic or aromatic polyisocyanate compound (C) and finally c) reacting the reaction product from stage b) with a polyalkylene oxide compound (D) of the general formula (I) in which R<SUP>1 </SUP>is H or a linear or branched and optionally unsaturated aliphatic hydrocarbon radical having 1 to 12 C atoms, R2 is a linear or branched and optionally unsaturated aliphatic hydrocarbon radical having 1 to 30 C atoms or phenyl, m is from 0 to 250, n is from 3 to 350 and x is from 1 to 12, and the ethylene oxide or higher alkylene oxide units can be arbitrarily distributed in the polyalkylene oxide compound (D). The polymer compounds proposed in accordance with the invention are exceptionally suitable as agents for preventing or suppressing efflorescence on surfaces of cured, hydrometrically settable building materials and/or for hydrophobization of the corresponding hydraulically settable systems. Moreover, owing to the admixtures proposed in accordance with the invention, the corresponding products absorb substantially less water, with the result that frost damage and rapid rusting of the steel reinforcement can be substantially reduced.
Patent DK-1996180-T3 (DK)
Inventor: BROWN DAVID RYALL
IPC: A61K31/427
Filed: 2007-03-22
Granted: 2011-10-31
Abstract: Compounds of formula (I) have antibacterial activity: wherein R represents hydrogen or 1, 2 or 3 optional substituents; W is ═C(R1)—; R1 is hydrogen and R2 is hydrogen, methyl, or fluorine; or R1 and R2 taken together are —CH2—, —CH2CH2, —O—, or, in either orientation, —O—CH2— or —OCH2CH2—; and R3 is a radical of formula (Alk1)m-(Z)p-(Alk2)n-Q.
Patent DK-1994006-T3 (DK)
Inventor: SIROL SABINE
IPC: C07D217/26
Filed: 2007-03-07
Granted: 2011-01-03
Abstract: The present invention discloses active oligomerisation or polymerisation catalyst systems based on imino-quinolinol complexes.
Patent DK-2094462-T3 (DK)
Inventor: HOFMANN MICHAEL
IPC: B29B17/00
Filed: 2007-11-16
Granted: 2011-11-14
Abstract: The recycling process involves foils and scraps of thicker plastic sorted out in a pre-sorting phase being ground into flakes or particles and refining them with water in a toothed disc refiner (26) whose teeth are engaged with each other with the teeth spaced out on concentric circles, The gaps between the teeth of one of them are of a size to allow thick solid pieces through for subsequent grinding into flakes and fine grains.
Patent DK-2154976-T3 (DK)
Inventor: CHOLLET PASCAL
IPC: A01N43/707
Filed: 2008-05-20
Granted: 2011-10-17
Abstract: The invention relates to a method of controlling insects in the family  Nitidulidae  using the compound 4,5-dihydro-6-methyl-4-(3-pyridylmethyleneamino)-1,2,4-triazin-3(2 H )-one and also encompasses the use of compositions comprising 4,5-dihydro-6-methyl-4-(3-pyridylmethyleneamino)-1,2,4-triazin-3(2 H )-one for controlling  Nitidulidae,  in particular pollen beetles as well as the preparation of said compound and/or compositions for use in controlling  Nitidulidae.  In particular, the invention relates to the use of 4,5-dihydro-6-methyl-4-(3-pyridylmethyleneamino)-1,2,4-triazin-3(2 H )-one and/or compositions comprising this compound in controlling such insects in crops of useful plants, in particular flowering crops and/or flowering ornamental plants.
Patent DK-2077268-T3 (DK)
Inventor: FURNEAUX RICHARD HUBERT
IPC: C07D491/056
Filed: 2000-04-07
Granted: 2017-06-06
Abstract: The invention provides a compound of the formula:   
wherein Y is an unsubstituted or substituted alkyl or arylalkyl group having 1 to 8 carbon atoms, as well as a process of preparing said compound.  The invention also provides a process of preparing the compound 3H,5H-pyrrolo[3,2-d]pyrimidin-4-one, comprising the step of reacting a compound of the formula (A) defined above with a reagent capable of delivering a formyl equivalent.  The invention also provides a process of preparing the compound 2-amino-3 H ,5 H -pyrrolo[3,2- d ]pyrimidin-4-one, comprising the step of reacting the compound 2-(N-dimethylaminomethylene)amino-6-(2-dimethylaminovinyl)-5-nitropyrimid-4-one with a reagent capable of reducing the nitro group, to produce the compound 2-amino-3 H ,5 H- pyrrolo[3,2- d ]pyrimidin-4-one.
Patent DK-2309656-T3 (DK)
Inventor: KOGA HISAO
IPC: H04B3/54
Filed: 2006-10-12
Granted: 2013-05-13
Abstract: A communication apparatus repeatedly outputs a first multi-carrier signal SS during predetermined periods T1, T2, T3, ···, and outputs a second multi-carrier signal RS whose phase vector is different from that of the first multi-carrier signal SS, at a predetermined timing based on the first multi-carrier signal SS. The communication apparatus further detects the second multi-carrier signal RS output from another communication apparatus, which uses a different communication method from the communication apparatus. Accordingly, both communication apparatuses can differentiate the first multi-carrier signal SS from the second multi-carrier signal RS without performing relatively cumbersome modulation and other processes.